A potential animal model for studying CF heterozygote advantage: Genetic variation in theophylline-inducible colonic chloride currents among inbred strains of mice by Sweet, Ann M. et al.
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY 47, 97-102 (1992) 
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A Potential Animal Model for Studying CF Heterozygote Advantage: 
Genetic Variation in Theophylline-Inducible Colonic Chloride 
Currents among Inbred Strains of Mice 
We have used Ussing chambers to measure chloride secretion by colonic segments (mu- 
cosa, muscularis, and serosa) from various inbred strains of mice. We found lower theo- 
phylline-induced Cl- secretion in the DBA/U than in the C57BL/6J strain. Their F, showed 
significantly higher levels of Cl- secretion than did the C57BL/6J parental strain while 
colonic segments from five recombinant inbred B x D lines ranged between the C57BL/6J 
and F, values. No major component of the variation appeared to be associated with alleles 
of the met oncogene region of chromosome 6 or the H-2 region of chromsome 17. o 1992 
Academic Press. Inc. 
Cystic fibrosis is an autosomally inherited recessive disease impairing the se- 
cretory ability of the epithelia of the pancreas, the bronchi, and the sweat gland 
secretory coil, as well as reabsorption into the sweat ducts. It is known to affect 
the regulation of apical chloride channels (l-3); the defective gene has been 
mapped to the 7q31 region of chromosome 7 (4) and has recently been cloned 
(5). Research into this illness has been slowed by the absence of animal models. 
The physiology of the mouse colonic epithelium can be studied by measuring 
the short circuit current (1s~) in an Ussing chamber using a voltage clamp. Putative 
chloride secretion can be identified by two methods: by blockade (6) using bu- 
metanide [3-(aminosulfonyl)-5-(butylamino)-4-phenoxybenzoic acid] or induction 
by maneuvers which are expected to elevate cellular CAMP (2). The loop diuretic, 
bumetanide, blocks the basolateral Na+ , K+ , 2 Cl- cotransporter which is re- 
sponsible for Cl- entry into the cells. Elevating cytosolic CAMP is thought to 
activate apical Cl- channels and promote Cl- exit from the cell to the lumenal 
side. In this study, both methods were used to identify chloride secretory com- 
ponents of Isc. The defect associated with cystic fibrosis affects chloride channel 
gating in response to elevations of CAMP (l-3). 
The use of recombinant inbred (RI) mouse strains for genetic studies has been 
well established (7). Once a theophylline [3,7-dihydro-1,3-dimethyl-lH-purine- 
2,6-dionel-inducible chloride secretion variation had been identified for two such 
strains, the genetics of the variation in RI strains was then examined to determine 
if there are genetic correlations with chloride secretion. The met oncogene is 
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known to map near the cystic fibrosis region in man (8), and has a homologous 
region on mouse chromosome 6 (9). Using the gene as a marker, we determined 
if a major genetic component of chloride secretion is linked to this region. In 
addition, we searched for any possible H-2 component of the theophylline-induced 
Cl- secretion since H-2 influences several components of the CAMP response 
(10,ll). 
MATERIALS AND METHODS 
Mice used in this study were obtained from the Jackson Laboratories (Bar 
Harbor, ME) or bred from such stocks. The mice were maintained in a light- 
controlled room until sacrifice by cervical dislocation. 
The excised colon was placed at 0°C in mouse Ringer’s solution (120 mM NaCl, 
25 mM NaHC03, 2.4 mM KH2P04, 0.6 mM KH2P04, 2 mM KCI, 1.2 mM CaC12, 
and 10 mM glucose), where it was flushed of its contents and the attached mesentery 
removed. The fragility of the epithelium did not permit the removal of the muscle. 
Colon segments were mounted in a OS-cm2 gas lift Ussing chamber attached to 
an Iowa Bioelectronics voltage clamp. The circulating Ringer’s solution was buff- 
ered with 95% O2 and 5% CO2 and maintained by a water jacket at 37°C. 
For the bumetanide treatments, each segment was treated with 100 mM amiloride 
on the mucosal side 9 min after mounting to block electrogenic Na+ absorption, 
followed by 100 mM bumetanide on the serosal side 15 min after mounting. The 
response to bumetanide was measured as a percentage decrease in the short-circuit 
current. 
In the theophylline treatments, 10 mM theophylline was added to both the 
serosal and mucosal sides 9 min after mounting, sometimes followed by 100 mM 
bumetanide on the serosal side 15 min after mounting (to assess viability). The 
response to theophylline was recorded as the absolute increase in short-circuit 
current. 
To determine if a significant genetic component of chloride secretion variation 
was linked to met, Southern analyses were performed (12): DNA from five 
DBA/2J x C57BL/6J recombinant inbred lines (lines 2, 12, 18, 23, and 25) were 
digested with EcoRI, as an RFLP between DBA/2J and C57BL/6J had previously 
beenidentified for this enzyme (13). The met oncogene probe, met G, was obtained 
from Michael Dean (14) and the insert was labeled with Amersham’s multiprime 
oligolabeled kit (Amersham, Arlington Heights, IL). Blots were hybridized over- 
night in Collaborative Research hybridization solution (10% dextran sulfate, 30% 
formamide, 1 M NaCl, 0.5 M Tris, 25 mM EDTA, 2.5 mg/ml sonicated salmon 
sperm DNA) at 50°C. Final washes were at 65°C in 2 x SSC, 0.1% SDS. 
RESULTS 
We initially searched for quantitative variations in bumetanide inhibitable spon- 
taneous Isc. To establish optimum experimental conditions and eliminate possible 
variables, a number of parameters were examined. Proximal, middle, and distal 
segments from the same animal were mounted from l-year-old females to deter- 
mine which segment gave the best response. Middle and distal segments were 
mounted 40, 70, and 100 min after sacrifice to determine if a decrease in response 
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TABLE 1 
Theophylline-Induced Isc in Inbred Mouse Strains 









Males + females, 
2-4 months 
Males + females, 
2-4 months 
Males, 2 months 
Females, 2 months 
Females, 2 months 
Females, 2 months 
Females, 2 months 
Females, 2 months 
14 17.20 k 3.72d DBA 
18 32.84 k 3.60 BL/6 
10 58.30 k 9.42 Heterozygous 
4 43.00 2 4.46 BL/6 
4 39.25 k 7.41 DBA 
5 40.60 f  5.53 DBA 
4 32.50 k 4.29 DBA 









a Means + standard error of the theophylline-induced transport expressed as the absolute increase 
in Isc for 0.5 cm* of mouse colon. 
b DBA = Those like the DBA/2J strain for the mer oncogene; BL/6 = those like the C57BL/6J 
strain for the met oncogene. 
’ H-2b or H-2d from Ref. (26). 
d Includes four readings of zero on segments shown to be viable (see text). 
could be detected. The results from these preliminary studies indicated that middle 
and distal colon segments should be mounted no later than 45 min after sacrifice 
(data not shown). Groups of mice representing five different inbred strains were 
also tested with some age and sex contrasts. No significant age difference was 
found in C57BL/6J females and no sex differences were found in the C57BL/6J 
and DBA/2J strains (date not shown). There was a suggestion of differences 
between some strains with C57BL/6J showing higher, and DBA/W showing lower, 
bumetanide inhibitable currents. Since temporal drift in the conditions affecting 
the apparatus were a probable cause of slight apparent differences, mice from 
the different strains were alternated in the apparatus within a short time period 
and no significant differences were found with C57BL/6J alternating with DBA/2J 
and alternating separately with BALB/6J-all with 6-week-old males (data not 
shown). 
We then studied theophylline-induced Isc among inbred strains of mice. The 
absolute increase in Isc induced by 10 mM theophylline in colons from DBA/W 
varied significantly (P < 0.005) from the response in C57BL/6J (Table 1). Colon 
segments from four of the DBA/2J mice had zero theophylline response but 
responded strongly to bumetanide demonstrating tissue viability (not shown). 
Segments from two DBA/2J colons that had not responded to 10 mM theophylline 
responded to 40 mM theophylline with a mean of 21.5 PA. To ensure that chloride 
secretion was being measured, mouse Ringer’s was replaced with a Ringer’s low 
in chloride and the colons from a DBA/W animal and one from a C57BL/6J 
were treated with theophylline as described previously. No induction of Isc was 
observed with the low chloride Ringers. 
In order to further define the genetics of the chloride secretion variable, Fr 
animals from a DBA/2 and C57BL/6J cross were also studied. The theophylline- 
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induced current for these animals was significantly larger than either of the parental 
strains (Table 1). The P values equaled 0.0002 for the comparison to the DBA/2J 
strain and 0.0049 from the comparison to the C57BL/6J strain. To determine if 
a significant genetic component of the chloride transport variation segregated 
and/or was linked to the met oncogene on chromosome 6, the chloride transport 
of recombinant inbred lines created from the matings of DBA/2J with C57BL/6J 
was examined. First each RI line was typed as either DBA/%like or C57BL/6J- 
like with respect to the met oncogene (Table 1). Next the theophylline-induced 
Isc for the C57BL/6J-like RI line (for met) was compared to that for the DBA/2J- 
like RI lines. The RI lines showed theophylline-induced Isc ranging between the 
C57BL/6J and F1 levels, and no correlation between typing for met and chloride 
secretion was observed. Finally, the values of theophylline-induced Isc for the H- 
2b RI lines were contrasted with those for the H-2d RI lines (Table 1). The H- 
2b lines had a somewhat lower level of inducible Cl- transport (37.75 ? 3.48 
compared to 39.38 + 4.00 for the H-2d lines). Although the probability of this 
result by chance is less than 0.05 (t = 2.52), we do not consider this a significant 
difference given the numbers of statistical tests performed (corrected required 
significance = O.OS/lO tests). 
DISCUSSION 
Currently, the basic defect in CF is believed to affect regulation of apical chloride 
channels. The sweat gland coil has been shown to have a diminished secretory 
response to /3-adrenergic agonists (15) and defective /?-adrenergic regulation of 
chloride ion permeability has been shown in cultured cells from sweat glands (16). 
The defect in /3-adrenergic responsiveness has been documented in other tissues 
such as submandibular glands (17) and the chloride transport defect has even 
been demonstrated in cultured skin fibroblasts (18). The predicted protein for the 
cloned gene has many properties expected for an ion channel (19). It is now 
generally believed that homozygotes for the CF gene are defective in regulation 
of Cl- transport at a site distal to CAMP-dependent protein kinase (reviewed in 
Ref. (20)). 
The CF defect in Cl- transport has been documented in the gut: ileum (21), 
jejunum (22), colon (21), and rectum (23) where normal CAMP-content and 
CAMP-dependent kinase (among other CAMP-binding proteins) were found. It 
has been hypothesized that such a defect might be advantageous in the presence 
of diarrhea-producing bacterial toxins (24) thus explaining the high frequency of 
the CF gene. The genetic variation in theophylline-inducible CF transport which 
we have found among inbred strains may be of the order to be expected between 
AF508 heterozygotes (AF508 is the most common mutant and is correlated with 
variability in sweat electrolyte levels (25)) and normal homozygotes. As such, it 
may be useful for studies on heterozygote selection. 
The significantly higher theophylline-induced Cl- secretion found in the 
C57BL/6J x DBA/U F1 colons is possibly an example of overdominance (“hybrid 
vigor”). However, inasmuch as the five RI lines studied do not show segregation 
of theophylline-induced chloride secretion to parental strain values but have values 
which range from those of the high strain to the higher value of the F1 mice, 
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multiple loci must affect colonic chloride secretion. No major gene effect on the 
quantitative variation in theophylline-induced colonic chloride secretion which we 
studied appears to segregate with the met locus on chromosome 6 or the H-2 
locus on chromosome 17. 
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